Literature DB >> 9263856

A theoretical model for the Gla-TSR-EGF-1 region of the anticoagulant cofactor protein S: from biostructural pathology to species-specific cofactor activity.

B O Villoutreix1, O Teleman, B Dahlbäck.   

Abstract

Protein S (PS), which functions as a species-specific anticoagulant cofactor to activated protein C (APC), is a mosaic protein that interacts with the phospholipid membrane via its gamma-carboxyglutamate-rich (Gla) module. This module is followed by the thrombin-sensitive region (TSR), sensitive to thrombin cleavage, four epidermal growth factor (EGF)-like modules and a last region referred to as the sex hormone binding globulin (SHBG) domain. Of these, the TSR and the first EGF-like regions have been shown to be important for the species-specific interaction with APC. Difficulties in crystallising PS have so far hindered its study at the atomic level. Here, we report theoretical models for the Gla and EGF-1 modules of human PS constructed using prothrombin and factor X experimental structures. The TSR was built interactively. Analysis of the model linked with the large body of biochemical literature on PS and related proteins leads to suggestions that (i) the TSR stabilises the calcium-loaded Gla module through hydrophobic and ionic interactions and its conformation depends on the presence of the Gla module; (ii) the TSR does not form a calcium binding site but is protected from thrombin cleavage in the calcium-loaded form owing to short secondary structure elements and close contact with the Gla module; (iii) the PS missense mutations in this region are consistent with the structural data, except in one case which needs further investigation; and (iv) the two PS 'faces' involving regions of residues Arg49-Gln52-Lys97 (TSR-EGF-1) and Thr103-Pro106 (EGF-1) may be involved in species-specific interactions with APC as they are richer in nonconservative substitution when comparing human and bovine protein S. This preliminary model helps to plan future experiments and the resulting data will be used to further validate and optimise the present structure.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9263856     DOI: 10.1023/a:1007912929828

Source DB:  PubMed          Journal:  J Comput Aided Mol Des        ISSN: 0920-654X            Impact factor:   3.686


  97 in total

1.  Tertiary templates for proteins. Use of packing criteria in the enumeration of allowed sequences for different structural classes.

Authors:  J W Ponder; F M Richards
Journal:  J Mol Biol       Date:  1987-02-20       Impact factor: 5.469

2.  Proposed structure of the A domains of factor VIII by homology modelling.

Authors:  Y Pan; T DeFay; J Gitschier; F E Cohen
Journal:  Nat Struct Biol       Date:  1995-09

3.  Regulation of activated protein C by thrombin-modified protein S.

Authors:  K Suzuki; J Nishioka; S Hashimoto
Journal:  J Biochem       Date:  1983-09       Impact factor: 3.387

4.  Comparative modeling of the three CP modules of the beta-chain of C4BP and evaluation of potential sites of interaction with protein S.

Authors:  B O Villoutreix; J A Fernández; O Teleman; J H Griffin
Journal:  Protein Eng       Date:  1995-12

5.  Novel type of very high affinity calcium-binding sites in beta-hydroxyasparagine-containing epidermal growth factor-like domains in vitamin K-dependent protein S.

Authors:  B Dahlbäck; B Hildebrand; S Linse
Journal:  J Biol Chem       Date:  1990-10-25       Impact factor: 5.157

6.  Destabilizing effect of proline substitutions in two helical regions of T4 lysozyme: leucine 66 to proline and leucine 91 to proline.

Authors:  T M Gray; E J Arnoys; S Blankespoor; T Born; R Jagar; R Everman; D Plowman; A Stair; D Zhang
Journal:  Protein Sci       Date:  1996-04       Impact factor: 6.725

7.  Structural investigation of the alpha-1-antichymotrypsin: prostate-specific antigen complex by comparative model building.

Authors:  B O Villoutreix; H Lilja; K Pettersson; T Lövgren; O Teleman
Journal:  Protein Sci       Date:  1996-05       Impact factor: 6.725

8.  Inhibition of the intrinsic factor X activating complex by protein S: evidence for a specific binding of protein S to factor VIII.

Authors:  S J Koppelman; T M Hackeng; J J Sixma; B N Bouma
Journal:  Blood       Date:  1995-08-01       Impact factor: 22.113

Review 9.  Protein S and C4b-binding protein: components involved in the regulation of the protein C anticoagulant system.

Authors:  B Dahlbäck
Journal:  Thromb Haemost       Date:  1991-07-12       Impact factor: 5.249

10.  Isolation and sequence of the cDNA for human protein S, a regulator of blood coagulation.

Authors:  A Lundwall; W Dackowski; E Cohen; M Shaffer; A Mahr; B Dahlbäck; J Stenflo; R Wydro
Journal:  Proc Natl Acad Sci U S A       Date:  1986-09       Impact factor: 11.205

View more
  15 in total

1.  Chemical synthesis and spontaneous folding of a multidomain protein: anticoagulant microprotein S.

Authors:  T M Hackeng; J A Fernández; P E Dawson; S B Kent; J H Griffin
Journal:  Proc Natl Acad Sci U S A       Date:  2000-12-19       Impact factor: 11.205

2.  Gly74Ser mutation in protein C causes thrombosis due to a defect in protein S-dependent anticoagulant function.

Authors:  Changming Chen; Likui Yang; Bruno O Villoutreix; Xuefeng Wang; Qiulan Ding; Alireza R Rezaie
Journal:  Thromb Haemost       Date:  2017-04-13       Impact factor: 5.249

3.  The Journey of Protein S from an Anticoagulant to a Signaling Molecule.

Authors:  V S Pilli; William Plautz; Rinku Majumder
Journal:  JSM Biochem Mol Biol       Date:  2016-08-08

4.  Phosphorylation of protein S by platelet kinases enhances its activated protein C cofactor activity.

Authors:  Fabian Stavenuiter; Andrew J Gale; Mary J Heeb
Journal:  FASEB J       Date:  2013-04-11       Impact factor: 5.191

5.  Implication of protein S thrombin-sensitive region with membrane binding via conformational changes in the gamma-carboxyglutamic acid-rich domain.

Authors:  D Borgel; P Gaussem; C Garbay; C Bachelot-Loza; T Kaabache; W Q Liu; B Brohard-Bohn; B Le Bonniec; M Aiach; S Gandrille
Journal:  Biochem J       Date:  2001-12-01       Impact factor: 3.857

Review 6.  Protein C anticoagulant and cytoprotective pathways.

Authors:  John H Griffin; Berislav V Zlokovic; Laurent O Mosnier
Journal:  Int J Hematol       Date:  2012-04-05       Impact factor: 2.490

7.  C-terminal residues of activated protein C light chain contribute to its anticoagulant and cytoprotective activities.

Authors:  Atsuki Yamashita; Yuqi Zhang; Michel F Sanner; John H Griffin; Laurent O Mosnier
Journal:  J Thromb Haemost       Date:  2020-03-05       Impact factor: 5.824

8.  Screening the molecular surface of human anticoagulant protein C: a search for interaction sites.

Authors:  B O Villoutreix; D G Covell; A M Blom; A Wallqvist; U Friedrich; B Dahlbäck
Journal:  J Comput Aided Mol Des       Date:  2001-01       Impact factor: 3.686

9.  Down-regulation of the clotting cascade by the protein C pathway.

Authors:  Fabian Stavenuiter; Eveline A M Bouwens; Laurent O Mosnier
Journal:  Hematol Educ       Date:  2013

10.  Plasma protein S residues 37-50 mediate its binding to factor Va and inhibition of blood coagulation.

Authors:  Mary J Heeb; Rolf M Mesters; José A Fernández; Tilman M Hackeng; Ryon K Nakasone; John H Griffin
Journal:  Thromb Haemost       Date:  2013-05-23       Impact factor: 5.249

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.